Back to search

Article

Differential peripheral immune dynamics underlie therapeutic response to chemotherapy and chemo-immunotherapy in triple-negative breast cancer

2026-05-01

Abstract excerpt

Triple-negative breast cancer (TNBC) remains the most aggressive breast cancer subtype, with limited treatment options and variable response to immune checkpoint inhibitors. While tumor-infiltrating lymphocytes have been extensively studied, the integration of system-level peripheral immune dynamics with mechanistic immune regulation underlying therapeutic response and resistance remain poorly defined. Here, we in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c7b139b1-2ea2-50c0-98fb-47bdf5f5c2b7
DOI
10.64898/2026.04.28.721416
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Differential peripheral immune dynamics underlie therapeutic response to chemotherapy and chemo-immunotherapy in triple-negative breast cancerDOI 10.64898/2026.04.28.721416
A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancerSemantic proximity
A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer.Semantic proximity
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.Semantic proximity
A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapiesSemantic proximity
A Comprehensive Immunologic Portrait of Triple-Negative Breast CancerSemantic proximity
Maximizing the Anti-tumor Potential of Immune Checkpoint Blockade through Modulation of Myeloid-specific CXCL16 and STAT1 SignalingSemantic proximity
Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer.Semantic proximity
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancerSemantic proximity
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancerSemantic proximity
Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacySemantic proximity
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsSemantic proximity
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity
Select a neighboring publication to make it the new centre.